BehaVR

What BehaVR does

BehaVR is a privately held US-based digital therapeutics company founded in 2016 in Elizabethton, Kentucky, that develops evidence-based virtual reality (VR) and extended reality (XR) therapies for mental and behavioral health. The company's platform translates clinical science — education, mindfulness, and meta-cognition techniques — into immersive VR experiences targeting anxiety, stress, fear, pain, addiction, maternal mental health, and serious mental illness. Core products include the flagship BehaVR Digital Therapeutics Platform, the CenteredVR stress reduction program co-developed with Johns Hopkins Medicine, and the GAMEChange VR serious mental illness treatment acquired through the December 2022 merger with OxfordVR. Underlying technology is a proprietary VR/XR content architecture rather than AI/ML-driven personalization, with clinical validation generated through academic research partnerships.

The company serves four primary customer segments: individual consumers (B2C self-serve), healthcare providers (clinicians and health systems prescribing VR therapy), employers offering VR-based employee wellness benefits, and health plan members accessing VR therapeutics as a covered benefit. Strategic partnerships with Sumitomo Pharma, University of Utah (NIH-funded MORE program for opioid use disorder), Johns Hopkins Medicine, Evidence in Motion (EIM), and Sonder Health anchor both clinical credibility and distribution. The December 2022 transatlantic merger with OxfordVR consolidated the largest evidence-based VR behavioral therapeutics platform and was supported by a $13 million Series B round led by Optum Ventures and Oxford Science Enterprises.

BehaVR's business model is subscription/recurring B2B enterprise sales to healthcare organizations, employers, and health plans, supplemented by direct-to-consumer access. Pricing is not publicly disclosed but is consistent with per-user licensing or subscription arrangements. The company has raised approximately $21 million in cumulative disclosed funding across seed, later-stage, and Series B rounds, operates with 11–50 employees, and is headquartered in the United States with expanded UK operations post-OxfordVR merger. Geographic markets served include North America, with claimed global distribution reach through enterprise channels.

Name

BehaVR

Legal name

BehaVR

Website

https://BehaVR.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

BehaVR is a US-based digital therapeutics company that develops evidence-based virtual reality therapies for mental and behavioral health, serving healthcare providers, employers, health plans, and consumers with immersive programs for anxiety, pain, stress, maternal health, addiction, and serious mental illness.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industry

VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics) (MPAFAGAG)

Keywords

• Virtual reality therapeutics
• Digital mental health
• Behavioral health solutions
• VR-based therapy
• Mental wellness programs

Headquarters

HQ city

Elizabethtown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. VR Digital Therapeutics Licensing/Treatment Services: BehaVR generates revenue through providing VR-based mental health treatments, likely structured as healthcare provider partnerships, employer wellness programs, and health plan integrations
2. Healthcare Enterprise Sales: Direct B2B sales to healthcare providers, employers offering employee wellness programs, and health plan members seeking mental health support through VR therapeutics

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

BehaVR develops and delivers evidence-based virtual reality (VR) and extended reality (XR) digital therapeutics for mental and behavioral health conditions including anxiety, stress, chronic pain, addiction, maternal health, and serious mental illness. The platform combines education, mindfulness, and meta-cognition techniques in immersive VR experiences, distributed through dedicated audience channels for individual consumers (For Myself), healthcare providers (My Patients), employers (My Employees), and health plans (My Members).

Product overview

BehaVR is a single unified VR digital therapeutics platform that translates proven science into immersive and engaging XR experiences for mental and behavioral health. The platform incorporates education, mindfulness, and meta-cognition to help users confront and address traumas, triggers, and fears. The core BehaVR platform is augmented by the acquired OxfordVR product line (GAMEChange VR) and the collaborative CenteredVR program developed with Johns Hopkins Medicine. The platform offers targeted programs across multiple focus areas: Anxiety Regulation (stress, anxiety, fear exposure), Pain Management, Maternal Health, Mental Wellness, and Serious Mental Illness (via GAMEChange VR).

Differentiator

Problem solved

Functional benefit

Brands

• GameChangeVR: VR platform for serious mental illness treatments
• CenteredVR

Products and services

• BehaVR Digital Therapeutics Platform
• CenteredVR
• GAMEChange VR
• Anxiety Regulation Program
• Pain Management Program
• Maternal Health Program
• Mental Wellness Program

Quantifiable outcome

• Mindfulness-Oriented Recovery Enhancement (MORE) program has potential to bring innovative treatment to millions of Americans suffering from opioid use disorder
• +1 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• OxfordVRcoreStrategic or Co-development Partner · 13 December 2022Transatlantic merger combining BehaVR's US market presence with OxfordVR's UK-based VR mental health research. The merger created the largest VR platform for evidence-based digital behavioral therapies and was supported by $13 million Series B funding.
• Sumitomo Pharma Co., Ltd.minorStrategic or Co-development PartnerStrategic collaboration leveraging VR technology for behavioral mental health challenges. Sumitomo Pharma's Frontier Business Office contributes global business development expertise.
• University of Utah College of Social WorkminorStrategic or Co-development PartnerNIH-funded joint research project on Mindfulness-Oriented Recovery Enhancement (MORE) program for opioid use disorder. Dr. Eric Garland leads the collaboration with BehaVR.
• Johns Hopkins MedicineminorStrategic or Co-development PartnerCollaboration on CenteredVR, a VR-based stress reduction program designed to make mental health support accessible and convenient for individuals.
• EIM (Evidence in Motion)minorStrategic or Co-development PartnerPartnership for pain science research and VR-based pain management treatment development. Dr. Adriaan Louw serves as Director of Pain Science.
• Sonder HealthminorStrategic or Co-development PartnerPartnership combining telemedicine and VR technologies to provide innovative solutions for women's perinatal health and their families.

Scale indicators3 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Calm Health: Calm Health is the B2B arm of Calm extending its consumer meditation platform into employer, payer, and provider channels. It competes with BehaVR's enterprise mental wellness offering with a much larger consumer brand and lower-friction delivery model.
• Headspace Health: Headspace Health (Ginger merger) offers a broad mental wellness platform to employers and health plans, including a clinician-on-demand service. It is a larger incumbent competing for the same employer and health plan mental health budgets as BehaVR.

Direct peers

• XRHealth: XRHealth operates a VR telehealth platform delivering clinician-supervised virtual reality therapy across pain, anxiety, and rehabilitation indications. It directly overlaps with BehaVR's enterprise-plus-clinician model and target indications.
• AppliedVR: AppliedVR develops VR-based digital therapeutics, most notably for chronic pain (RelieVRx, FDA-authorized). It is the closest direct competitor to BehaVR in the prescription-grade VR therapeutics category and shares the same hardware-dependency profile.
• Big Health: Big Health produces digital therapeutics for insomnia (Sleepio) and anxiety (Daylight), sold through employers, health plans, and providers. It directly competes with BehaVR's enterprise mental wellness channel and reimbursement strategy.
• Pear Therapeutics: Pear Therapeutics pioneered prescription digital therapeutics for substance use disorder and insomnia before its 2023 bankruptcy. It is the most directly comparable precedent for BehaVR's business model, including its cautionary capital and reimbursement trajectory.
• Akili Interactive: Akili Interactive is a prescription digital therapeutics company (EndeavorRx for ADHD, adult cognition products) pursuing FDA authorization and payer reimbursement. It is a direct peer in evidence-based software-as-a-medical-device behavioral therapeutics.

Emerging players

• Mursion: Mursion provides VR-based simulation training for soft skills, healthcare communication, and behavioral scenarios. It is an adjacent VR-for-behavioral-change peer that demonstrates parallel enterprise applications of immersive technology but does not target clinical DTx.
• Woebot Health: Woebot Health develops AI-driven conversational mental health therapeutics, including regulated DTx products for postpartum depression. It overlaps with BehaVR's maternal health and behavioral health DTx focus using a different (chat-based) modality.
• Limbic: Limbic is a UK-based digital mental health company offering AI-supported therapy tools to NHS and private providers. It is geographically adjacent to BehaVR's UK operations (via OxfordVR) and a comparable digital behavioral health provider with NHS traction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BehaVR_al
• YouTubeyoutube.com/channel/UCsCPAPslxFgDp-ayxMGt_6Q
• Facebookfacebook.com/VRForBehavioralHealth
• Instagraminstagram.com/behavr_experience/?hl=en
• LinkedInlinkedin.com/company/behavr

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BehaVR